UK Startups Join TMC to Drive Innovation in Patient Safety, Maternal Health, Trauma, Neurology, and Surgery in U.S.

(Houston, TX) – Texas Medical Center (TMC), in partnership with Innovate UK, has announced the third cohort of companies selected for a specialized accelerator at the TMC Innovation Factory. The program welcomes eight medical device startups addressing critical challenges in behavioral health, maternal trauma and drug delivery, fatal blood loss, emergency monitoring, dementia and other neurological conditions, and the development of more precise, minimally invasive surgical solutions.

Through the Innovate UK Global Incubator Programme, an extension of the TMC–United Kingdom BioBridge, founders will gain access to resources, curated networking opportunities, and expert mentorship across TMC’s medical campus and broader networks, helping them refine their U.S. go-to-market strategy.

“We are excited to welcome this new cohort and look forward to seeing their innovations make a difference at TMC and beyond,” said Tom Luby, Chief Innovation Officer of the Texas Medical Center. “Since the launch of our first specialized accelerator through our Biobridge partnerships, we’ve seen commitment and ingenuity from entrepreneurs tackling complex medical challenges. They understand first-hand the realities of these conditions, and TMC provides a unique place to brainstorm, bring ideas to life, test, and commercialize solutions for impact here and around the world.”

The third cohort brings a new approach to behavioral care, with CareLoop Health and Safehinge Primera introducing technologies to reduce risk and support prevention, helping clinicians and caregivers prioritize patient safety and stability.

PeriPear and Calla Lily are advancing women’s and maternal health through a wearable device and a vaginal drug delivery system.

ACT Medical is driving innovation in trauma care, focusing on preventing blood loss from knife wounds.

OmniBuds, the world’s first sensory earable, monitors all five vital signs continuously with high sensing accuracy.

Neu Health focuses on neurology and chronic condition management, providing a smartphone platform to monitor clinically relevant neurological symptoms for people living with Parkinson’s disease and Dementia.

Nami Surgical is developing miniaturized ultrasonic surgical scalpels for robotic surgery, enhancing precision and efficiency and potentially transforming minimally invasive procedures.

“We have seen companies grow exponentially through the Innovate UK Global Incubator Programme, and these innovations have the potential to transform medical treatments. TMC offers an ecosystem where a sophisticated healthcare market, access to capital, world-class talent, regulatory expertise, and cutting-edge research come together in one place,” said Jon Hazell, Partnership Manager – North America and Global Incubator at Innovate UK. “Our goal is that, by leveraging TMC’s academic medical centers and clinical trial infrastructure, UK companies can achieve validation, build partnerships, continue to innovate and accelerate adoption of their products and technologies.”

The third cohort began its inaugural in-person session at TMC Innovation Factory on Monday, September 8, and will continue through September 12. Over the next five months, founders will participate in a tailored program with TMC specialists to refine their strategic plans and enhance their incubation experience.

###

About Texas Medical Center (TMC): TMC is the world’s most comprehensive life science ecosystem at the forefront of advancing life sciences. TMC is on a mission to further accelerate the pace of healing by harnessing our collective expertise in innovation, research, development, production, and patient care within a single, centralized medical ecosystem. With over 70+ million square feet and 120,000+ employees, TMC is leveraging the collective power by pioneering a revolutionary life sciences initiative to house the entire treatment of life cycle from discovery to delivery, within a single, world-class medical complex, on a scale never before seen.

About Texas Medical Center Innovation (TMCi): Texas Medical Center Innovation forms, fosters, recruits, and funds healthcare companies worldwide that are writing the future of healthcare. TMCi performs diligence on the companies seeking to progress toward clinical and business milestones in collaboration with Texas Medical Center member institutions and our global network of advisors and embedded corporate partners. We align these resources through our globally recognized programs:  Biodesign, Accelerator for Cancer Therapeutics, and Health Tech.

 

About Innovate UK: Innovate UK, part of UK Research and Innovation, is the UK’s innovation agency. It works to create a better future by inspiring, involving and investing in businesses developing life-changing innovations. Its mission is to help companies to grow through their development and commercialisation of new products, processes and services, supported by an outstanding innovation ecosystem that is agile, inclusive and easy to navigate